Temasek Holdings (Private) LTD Bei Gene, Ltd. Transaction History

Temasek Holdings (Private) LTD

$20.3 Billion
Q2 2025

A detailed history of Temasek Holdings (Private) LTD transactions in Bei Gene, Ltd. stock. As of the latest transaction made, Temasek Holdings (Private) LTD holds 1,010,465 shares of BGNE stock, worth $229 Million. This represents 1.13% of its overall portfolio holdings.

Number of Shares

1,010,465

Previous 993,752 1.68%

Holding current value

$229 Million

Previous $225 Million 1.68%

% of portfolio

1.13%

Previous 1.15%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	N/A	16,713 Added 1.68%	1,010,465 $229 Million
Q1 2025 May 16, 2025	SELL	$175.1 - $226.71 $93.1 Million - $121 Million	-531,577 Reduced 34.85%	993,752 $225 Million
Q4 2024 Feb 14, 2025	SELL	$174.72 - $246.04 $151 Million - $212 Million	-863,247 Reduced 36.14%	1,525,329 $282 Million
Q3 2024 Nov 14, 2024	BUY	$143.93 - $224.51 $344 Million - $536 Million	2,388,576 New	2,388,576 $536 Million
Q3 2023 Nov 14, 2023	BUY	$179.87 - $225.13 $1.09 Million - $1.36 Million	6,059 Added 0.2%	3,014,171 $542 Million
Q2 2023 Aug 14, 2023	BUY	$178.3 - $266.78 $7.43 Million - $11.1 Million	41,649 Added 1.4%	3,008,112 $536 Million
Q1 2023 May 15, 2023	SELL	$215.53 - $274.5 $30.9 Million - $39.4 Million	-143,507 Reduced 4.61%	2,966,463 $639 Million
Q3 2022 May 15, 2023	BUY	$131.8 - $202.24 $18.9 Million - $29 Million	143,507 Added 4.84%	3,109,970 $419 Million
Q3 2022 Nov 14, 2022	BUY	$131.8 - $202.24 $18.9 Million - $29 Million	143,507 Added 4.84%	3,109,970 $419 Million
Q1 2022 May 15, 2023	SELL	$146.52 - $269.56 $21 Million - $38.7 Million	-143,507 Reduced 4.61%	2,966,463 $559 Million
Q1 2022 May 16, 2022	BUY	$146.52 - $269.56 $1.33 Million - $2.45 Million	9,100 Added 0.31%	2,966,463 $559 Million
Q4 2021 Feb 14, 2022	BUY	$248.56 - $389.34 $10.7 Million - $16.8 Million	43,050 Added 1.48%	2,957,363 $801 Million
Q3 2021 Nov 15, 2021	BUY	$249.6 - $403.14 $41.5 Million - $67 Million	166,257 Added 6.05%	2,914,313 $1.06 Billion
Q2 2021 Aug 16, 2021	BUY	$292.75 - $367.01 $380,867 - $477,480	1,301 Added 0.05%	2,748,056 $943 Million
Q1 2021 May 17, 2021	BUY	$260.64 - $382.12 $25.3 Million - $37.1 Million	97,136 Added 3.67%	2,746,755 $956 Million
Q2 2020 Aug 14, 2020	BUY	$123.9 - $195.41 $25 Million - $39.5 Million	202,028 Added 8.25%	2,649,619 $499 Million
Q1 2020 May 15, 2020	BUY	$121.84 - $173.19 $21.6 Million - $30.7 Million	177,491 Added 7.82%	2,447,591 $301 Million
Q1 2018 May 15, 2018	BUY	$97.41 - $177.22 $96.4 Million - $175 Million	990,100 Added 77.35%	2,270,100 $381 Million
Q4 2017 Feb 14, 2018	BUY	$79.6 - $114.73 $71.6 Million - $103 Million	900,000 Added 236.84%	1,280,000 $125 Million
Q3 2017 Nov 14, 2017	BUY	$66.19 - $103.46 $25.2 Million - $39.3 Million	380,000	380,000 $39.3 Million

Others Institutions Holding BGNE

# of Institutions

269

Shares Held

32.2M

Call Options Held

113K

Put Options Held

106K

View Full List

About BeiGene, Ltd.

Ticker BGNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,700,000
Market Cap $23.5B
Description
BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...

More about BGNE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Temasek Holdings (Private) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Temasek Holdings (Private) LTD with notifications on news.

Account

Temasek Holdings (Private) LTD Bei Gene, Ltd. Transaction History